• Home
  • About Us
    • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Management Team
    • Careers
  • For Researchers
    • Paxalisib
    • EVT801
    • Collaborating with Kazia
    • Publications and Presentations
  • For Partners
    • Our Current Partners
    • What We Are Looking For
  • For Patients
    • Accessing Kazia Drug Candidates in Clinical Trials
    • Accessing Kazia Drug Candidates for Compassionate Use
    • Resources for Patients
  • For Investors
    • ASX Announcements
    • SEC Filings
    • Corporate Presentations
    • Annual Reports
    • Financial Reports
    • AGM
    • EGM
    • Share Purchase Plan
    • Investor Newsletters
    • Corporate Governance
    • Shareholder Services
  • Media Centre
    • Overview
    • Latest News
    • Video
    • Coverage
  • Contact
    • Contact Us
    • Subscribe to email alerts
Kazia Therapeutics Limited
Heading &
Sub-heading can be edited through HQI
Home > For Researchers > Publications and Presentations
  • Paxalisib
  • EVT801
  • Collaborating with Kazia
  • Publications and Presentations

Publications and Presentations


 
25-Oct-2022    Poster at Int. Congress of the Society for Melanoma Research  
 
3-Jun-2022    Paxalisib phase II study poster presented as ASCO 2022  
 
4-Jun-2021    Kazia Therapeutics to present at LD Micro Invitational XI  
 
21-Nov-2020    Paxalisib poster presented at SNO (virtual meeting)  
 
22-Jun-2020    Paxalisib poster presented at AACR (virtual meeting)  
 
1-Jun-2020    Paxalisib poster presented at ASCO (virtual meeting)  
 
8-Apr-2020    Ellingson et al (2020) - multiparametric MR-PET in GDC-0084 P1  
 
14-Jan-2020    Wen et al (2020) GDC-0084 phase 1 in glioblastoma  
 
20-Sep-2019    GDC-0084 Poster presented at EANO (Lyon, France)  
 
22-Feb-2019    Ippen et al (2019) - GDC-0084 in brain mets (prelinical)  
 
14-Nov-2018    GDC-0084 Poster presented at SNO  
 
9-Sep-2016    Salphati et al (2016) - Brain Distribution and Efficacy of GDC-0084  
 
3-Jun-2016    GDC-0084 Poster presented at ASCO  
 
4-Mar-2016    GDC-0084 Poster presented at ASCPT  
 
16-Feb-2016    Heffron et al (2016) - Development of GDC-0084  
 
 

Quick Links

Contact Us

Kazia Therapeutics Limited
Three International Towers
Level 24, 300 Barangaroo Avenue
Sydney NSW 2000, Australia

info@kaziatherapeutics.com
https://www.kaziatherapeutics.com

Subscribe to Email Alerts

Which of the following group do you best fit?

 

Email Alerts

Subscribe to our Email Alerts

Follow Us

Copyright © Kazia Therapeutics Limited
Site Map Privacy Search
Design byspatialdesign Site by